ClearPoint Neuro (CLPT) Cash from Investing Activities (2011 - 2026)
ClearPoint Neuro (CLPT) posted Cash from Investing Activities of -$645000.0 for Q1 2026, down 159.28% sequentially from $1.1 million in Q4 2025, and down 252.46% YoY from $423064.5 in Q1 2025.
ClearPoint Neuro (CLPT) Cash from Investing Activities (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Cash from Investing Activities for 15 years, with the latest figure at -$645000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 252.46% year-over-year to -$645000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153000.0 (up 133.41% YoY) and the FY2025 annual result came in at $615000.0, up 323.64% from the prior year.
- Cash from Investing Activities fell to -$645000.0 in Q1 2026 per CLPT's latest filing, from $1.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $11.7 million in Q4 2022 and troughed at -$21.7 million in Q2 2022.
- A 5-year average of -$139466.7 and a median of -$185000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 31010.53% in 2022, down 62002.86% in 2022.
- Over 5 years, Cash from Investing Activities stood at $11.7 million in 2022, then tumbled by 101.6% to -$188000.0 in 2023, then slumped by 39.89% to -$263000.0 in 2024, then soared by 513.69% to $1.1 million in 2025, then plunged by 159.28% to -$645000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$645000.0, $1.1 million, and -$199000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | ClearPoint Neuro | 466.38 Mn | 436.98 Mn | 6.71 Mn | -214,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -214,000.00 |
| Jun 30, 2026 | -214,000.00 |
| Mar 31, 2026 | -645,000.00 |
| Mar 31, 2026 | -645,000.00 |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | -199,000.00 |
| Sep 30, 2025 | -199,000.00 |
| Jun 30, 2025 | -91,000.00 |
| Jun 30, 2025 | -91,000.00 |
| Mar 31, 2025 | -183,000.00 |
| Mar 31, 2025 | -183,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Sep 30, 2024 | -12,000.00 |
| Sep 30, 2024 | -12,000.00 |
| Dec 31, 2023 | -188,000.00 |
| Dec 31, 2023 | -188,000.00 |
| Sep 30, 2023 | -235,000.00 |
| Sep 30, 2023 | -235,000.00 |